Clinical Trials for Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer

Find clinical trials for pretreated unresectable locally advanced or metastatic her2+ breast cancer. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

NCT ID: NCT05458674

This clinical trial is studying a combination of three drugs—tucatinib, trastuzumab, and eribulin—to see how safe and effective they are for treating certain types of breast cancer. Specifically, t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Madison, Wisconsin, United States, Aurora, Colorado, United States +4 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions